Physician profile
William B Gilbert
NPI 1487715801
$1,889.91
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $114 · 2021: $70.94 · 2022: $407 · 2023: $234 · 2024: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $387.11 | 2019-2024 | Xtandi |
| Accord Healthcare, INC. | $280.13 | 2022-2024 | |
| Blue Earth Diagnostics | $134.99 | 2019-2024 | |
| Janssen Biotech, INC. | $108.70 | 2019 | |
| Pfizer INC. | $99.85 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $91.45 | 2019-2024 | Provenge |
| Abc Home Medical Supply, INC. | $80.23 | 2022-2024 | |
| C. R. Bard, INC. & Subsidiaries | $80.06 | 2019-2023 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $68.89 | 2019-2024 | Ams 700 |
| Neotract INC. | $62.42 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $49.47 | 2023 | Prolaris |
| Olympus America INC. | $44.77 | 2022-2024 | Itind System |
| Abbvie INC. | $44.21 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $41.26 | 2023 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $33.61 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $32.83 | 2024 | |
| Ferring Pharmaceuticals INC. | $31.57 | 2019 | |
| Travere Therapeutics, INC. | $31.25 | 2019-2022 | |
| Urovant Sciences INC | $30.65 | 2022 | |
| Endo USA, INC. | $24.98 | 2024 | Xiaflex |
| Becton, Dickinson and Company | $23.79 | 2022 | |
| Innovation Technologies INC | $18.76 | 2024 | Irrisept |
| Procept Biorobotics Corporation | $18.28 | 2023 | Aquabeam Robotic System |
| Dentsply Ih Ab | $17.64 | 2023 | Lofric |
| Tolmar Pharmaceuticals, INC. | $17.06 | 2019 | |
| Mission Pharmacal Company | $12.17 | 2019 | |
| Endo Pharmaceuticals INC. | $12.01 | 2020 | |
| Depuy Synthes Sales INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.